Guidelines for regulated cell death assays: a systematic summary, a categorical comparison, a prospective

X Hu, Z Li, R Lin, J Shan, Q Yu, R Wang… - Frontiers in cell and …, 2021 - frontiersin.org
Over the past few years, the field of regulated cell death continues to expand and novel
mechanisms that orchestrate multiple regulated cell death pathways are being unveiled …

Toward unraveling the complexity of simple epithelial keratins in human disease

MB Omary, NO Ku, P Strnad… - The Journal of clinical …, 2009 - Am Soc Clin Investig
Simple epithelial keratins (SEKs) are found primarily in single-layered simple epithelia and
include keratin 7 (K7), K8, K18–K20, and K23. Genetically engineered mice that lack SEKs …

Interleukin-6 as a therapeutic target in human ovarian cancer

J Coward, H Kulbe, P Chakravarty, D Leader… - Clinical cancer …, 2011 - AACR
Purpose: We investigated whether inhibition of interleukin 6 (IL-6) has therapeutic activity in
ovarian cancer via abrogation of a tumor-promoting cytokine network. Experimental Design …

Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial

JW Valle, H Wasan, A Lopes, AC Backen… - The Lancet …, 2015 - thelancet.com
Background Cisplatin and gemcitabine is the standard first-line chemotherapy regimen for
patients with advanced biliary tract cancer; expression of VEGF and its receptors is …

Translating cancer research into targeted therapeutics

JS de BONO, A Ashworth - Nature, 2010 - nature.com
The emphasis in cancer drug development has shifted from cytotoxic, non-specific
chemotherapies to molecularly targeted, rationally designed drugs promising greater …

Evaluation of circulating tumor cells and serological cell death biomarkers in small cell lung cancer patients undergoing chemotherapy

JM Hou, A Greystoke, L Lancashire… - The American journal of …, 2009 - Elsevier
Serological cell death biomarkers and circulating tumor cells (CTCs) have potential uses as
tools for pharmacodynamic blood-based assays and their subsequent application to early …

Cytokeratin 18-based modification of the MELD score improves prediction of spontaneous survival after acute liver injury

LP Bechmann, C Jochum, P Kocabayoglu, JP Sowa… - Journal of …, 2010 - Elsevier
BACKGROUND & AIMS: Predicting the probability of patients with acute liver failure (ALF) to
recover spontaneously is of major clinical importance. As apoptotic and necrotic cell death …

Highly sensitive detection of protein with aptamer-based target-triggering two-stage amplification

Z Zhang, C Zhang - Analytical chemistry, 2012 - ACS Publications
Highly sensitive detection of proteins is essential to biomedical research as well as clinical
diagnosis. However, so far most detection methods rely on antibody-based assays and are …

Fit-for-purpose biomarker method validation for application in clinical trials of anticancer drugs

J Cummings, F Raynaud, L Jones, R Sugar… - British journal of …, 2010 - nature.com
Clinical development of new anticancer drugs can be compromised by a lack of qualified
biomarkers. An indispensable component to successful biomarker qualification is assay …

Targeting TRAIL Death Receptors in Triple-Negative Breast Cancers: Challenges and Strategies for Cancer Therapy

M Kundu, YE Greer, JL Dine, S Lipkowitz - Cells, 2022 - mdpi.com
The tumor necrosis factor (TNF) superfamily member TNF-related apoptosis-inducing ligand
(TRAIL) induces apoptosis in cancer cells via death receptor (DR) activation with little toxicity …